446 related articles for article (PubMed ID: 14523097)
1. The neurofibromatosis 1 gene product neurofibromin regulates pituitary adenylate cyclase-activating polypeptide-mediated signaling in astrocytes.
Dasgupta B; Dugan LL; Gutmann DH
J Neurosci; 2003 Oct; 23(26):8949-54. PubMed ID: 14523097
[TBL] [Abstract][Full Text] [Related]
2. Requirement of Drosophila NF1 for activation of adenylyl cyclase by PACAP38-like neuropeptides.
Guo HF; The I; Hannan F; Bernards A; Zhong Y
Science; 1997 May; 276(5313):795-8. PubMed ID: 9115204
[TBL] [Abstract][Full Text] [Related]
3. Physical interaction between neurofibromin and serotonin 5-HT6 receptor promotes receptor constitutive activity.
Deraredj Nadim W; Chaumont-Dubel S; Madouri F; Cobret L; De Tauzia ML; Zajdel P; Bénédetti H; Marin P; Morisset-Lopez S
Proc Natl Acad Sci U S A; 2016 Oct; 113(43):12310-12315. PubMed ID: 27791021
[TBL] [Abstract][Full Text] [Related]
4. Glioma formation in neurofibromatosis 1 reflects preferential activation of K-RAS in astrocytes.
Dasgupta B; Li W; Perry A; Gutmann DH
Cancer Res; 2005 Jan; 65(1):236-45. PubMed ID: 15665300
[TBL] [Abstract][Full Text] [Related]
5. Cerebrospinal fluid proteomic analysis reveals dysregulation of methionine aminopeptidase-2 expression in human and mouse neurofibromatosis 1-associated glioma.
Dasgupta B; Yi Y; Hegedus B; Weber JD; Gutmann DH
Cancer Res; 2005 Nov; 65(21):9843-50. PubMed ID: 16267007
[TBL] [Abstract][Full Text] [Related]
6. Neurofibromatosis-1 heterozygosity impairs CNS neuronal morphology in a cAMP/PKA/ROCK-dependent manner.
Brown JA; Diggs-Andrews KA; Gianino SM; Gutmann DH
Mol Cell Neurosci; 2012 Jan; 49(1):13-22. PubMed ID: 21903164
[TBL] [Abstract][Full Text] [Related]
7. Neurofibromin regulates somatic growth through the hypothalamic-pituitary axis.
Hegedus B; Yeh TH; Lee DY; Emnett RJ; Li J; Gutmann DH
Hum Mol Genet; 2008 Oct; 17(19):2956-66. PubMed ID: 18614544
[TBL] [Abstract][Full Text] [Related]
8. Proteomic analysis reveals hyperactivation of the mammalian target of rapamycin pathway in neurofibromatosis 1-associated human and mouse brain tumors.
Dasgupta B; Yi Y; Chen DY; Weber JD; Gutmann DH
Cancer Res; 2005 Apr; 65(7):2755-60. PubMed ID: 15805275
[TBL] [Abstract][Full Text] [Related]
9. Mice with GFAP-targeted loss of neurofibromin demonstrate increased axonal MET expression with aging.
Su W; Xing R; Guha A; Gutmann DH; Sherman LS
Glia; 2007 May; 55(7):723-33. PubMed ID: 17348023
[TBL] [Abstract][Full Text] [Related]
10. Neurofibromin GTPase-activating protein-related domains restore normal growth in Nf1-/- cells.
Hiatt KK; Ingram DA; Zhang Y; Bollag G; Clapp DW
J Biol Chem; 2001 Mar; 276(10):7240-5. PubMed ID: 11080503
[TBL] [Abstract][Full Text] [Related]
11. Effect of neurofibromatosis type I mutations on a novel pathway for adenylyl cyclase activation requiring neurofibromin and Ras.
Hannan F; Ho I; Tong JJ; Zhu Y; Nurnberg P; Zhong Y
Hum Mol Genet; 2006 Apr; 15(7):1087-98. PubMed ID: 16513807
[TBL] [Abstract][Full Text] [Related]
12. Neurofibromatosis type 1 (NF1) tumor suppressor, neurofibromin, regulates the neuronal differentiation of PC12 cells via its associating protein, CRMP-2.
Patrakitkomjorn S; Kobayashi D; Morikawa T; Wilson MM; Tsubota N; Irie A; Ozawa T; Aoki M; Arimura N; Kaibuchi K; Saya H; Araki N
J Biol Chem; 2008 Apr; 283(14):9399-413. PubMed ID: 18218617
[TBL] [Abstract][Full Text] [Related]
13. Gene-targeted deletion of neurofibromin enhances the expression of a transient outward K+ current in Schwann cells: a protein kinase A-mediated mechanism.
Xu Y; Chiamvimonvat N; Vázquez AE; Akunuru S; Ratner N; Yamoah EN
J Neurosci; 2002 Nov; 22(21):9194-202. PubMed ID: 12417644
[TBL] [Abstract][Full Text] [Related]
14. Haploinsufficiency for the neurofibromatosis 1 (NF1) tumor suppressor results in increased astrocyte proliferation.
Gutmann DH; Loehr A; Zhang Y; Kim J; Henkemeyer M; Cashen A
Oncogene; 1999 Aug; 18(31):4450-9. PubMed ID: 10442636
[TBL] [Abstract][Full Text] [Related]
15. Nucleophosmin mediates mammalian target of rapamycin-dependent actin cytoskeleton dynamics and proliferation in neurofibromin-deficient astrocytes.
Sandsmark DK; Zhang H; Hegedus B; Pelletier CL; Weber JD; Gutmann DH
Cancer Res; 2007 May; 67(10):4790-9. PubMed ID: 17510408
[TBL] [Abstract][Full Text] [Related]
16. Neurofibromatosis 1: closing the GAP between mice and men.
Dasgupta B; Gutmann DH
Curr Opin Genet Dev; 2003 Feb; 13(1):20-7. PubMed ID: 12573431
[TBL] [Abstract][Full Text] [Related]
17. Neurofibromatosis-1 regulates mTOR-mediated astrocyte growth and glioma formation in a TSC/Rheb-independent manner.
Banerjee S; Crouse NR; Emnett RJ; Gianino SM; Gutmann DH
Proc Natl Acad Sci U S A; 2011 Sep; 108(38):15996-6001. PubMed ID: 21896734
[TBL] [Abstract][Full Text] [Related]
18. Loss of neurofibromin is associated with activation of RAS/MAPK and PI3-K/AKT signaling in a neurofibromatosis 1 astrocytoma.
Lau N; Feldkamp MM; Roncari L; Loehr AH; Shannon P; Gutmann DH; Guha A
J Neuropathol Exp Neurol; 2000 Sep; 59(9):759-67. PubMed ID: 11005256
[TBL] [Abstract][Full Text] [Related]
19. Neuronal NF1/RAS regulation of cyclic AMP requires atypical PKC activation.
Anastasaki C; Gutmann DH
Hum Mol Genet; 2014 Dec; 23(25):6712-21. PubMed ID: 25070947
[TBL] [Abstract][Full Text] [Related]
20. Neurofibromin regulates neural stem cell proliferation, survival, and astroglial differentiation in vitro and in vivo.
Dasgupta B; Gutmann DH
J Neurosci; 2005 Jun; 25(23):5584-94. PubMed ID: 15944386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]